These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 39394148)
1. NAD Xiong X; Hou J; Zheng Y; Jiang T; Zhao X; Cai J; Huang J; He H; Xu J; Qian S; Lu Y; Wang X; Wang W; Ye Q; Zhou S; Lian M; Xiao J; Song W; Xie C Cell Death Dis; 2024 Oct; 15(10):744. PubMed ID: 39394148 [TBL] [Abstract][Full Text] [Related]
2. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. Long AN; Owens K; Schlappal AE; Kristian T; Fishman PS; Schuh RA BMC Neurol; 2015 Mar; 15():19. PubMed ID: 25884176 [TBL] [Abstract][Full Text] [Related]
3. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Wang X; Hu X; Yang Y; Takata T; Sakurai T Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of nicotinamide mononucleotide on Alzheimer's disease through activating autophagy and anti-oxidative stress. Ma RY; Li L; Yang H; Zou B; Ma RX; Zhang Y; Wu MM; Chen P; Yao Y; Li J Biomed Pharmacother; 2024 Sep; 178():117199. PubMed ID: 39053426 [TBL] [Abstract][Full Text] [Related]
5. NAD Klimova N; Fearnow A; Long A; Kristian T Exp Neurol; 2020 Mar; 325():113144. PubMed ID: 31837320 [TBL] [Abstract][Full Text] [Related]
6. Nicotinamide mononucleotide ameliorates acute lung injury by inducing mitonuclear protein imbalance and activating the UPR Du SH; Shi J; Yu TY; Hu XX; He SM; Cao YY; Xie ZL; Liu SS; Li YT; Li N; Yu JB Exp Biol Med (Maywood); 2022 Jul; 247(14):1264-1276. PubMed ID: 35538652 [TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice. Klimova N; Long A; Kristian T J Neurosci Res; 2019 Aug; 97(8):975-990. PubMed ID: 30801823 [TBL] [Abstract][Full Text] [Related]
8. Honokiol improves cognitive impairment in APP/PS1 mice through activating mitophagy and mitochondrial unfolded protein response. Hou M; Bao W; Gao Y; Chen J; Song G Chem Biol Interact; 2022 Jan; 351():109741. PubMed ID: 34752757 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia. Park JH; Long A; Owens K; Kristian T Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541 [TBL] [Abstract][Full Text] [Related]
12. Nicotinamide mononucleotide improves the Alzheimer's disease by regulating intestinal microbiota. Zhao X; Kong M; Wang Y; Mao Y; Xu H; He W; He Y; Gu J Biochem Biophys Res Commun; 2023 Aug; 670():27-35. PubMed ID: 37271037 [TBL] [Abstract][Full Text] [Related]
13. Effect of alternating nicotinamide phosphoribosyltransferase expression levels on mitophagy in Alzheimer's disease mouse models. Zhao N; Xu B; Xia J; Wang J; Zhang X; Yan Q Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167288. PubMed ID: 38862096 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Kiss T; Nyúl-Tóth Á; Balasubramanian P; Tarantini S; Ahire C; Yabluchanskiy A; Csipo T; Farkas E; Wren JD; Garman L; Csiszar A; Ungvari Z Geroscience; 2020 Apr; 42(2):527-546. PubMed ID: 32056076 [TBL] [Abstract][Full Text] [Related]
15. Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer's Disease. Wu W; Yuan S; Tang Y; Meng X; Peng M; Hu Z; Liu W Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447179 [TBL] [Abstract][Full Text] [Related]
16. Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach. Alghamdi M; Braidy N J Alzheimers Dis; 2024; 101(s1):S467-S477. PubMed ID: 39422945 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Mononucleotide Supplementation Improves Mitochondrial Dysfunction and Rescues Cellular Senescence by NAD Wang H; Sun Y; Pi C; Yu X; Gao X; Zhang C; Sun H; Zhang H; Shi Y; He X Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499074 [TBL] [Abstract][Full Text] [Related]
18. Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS. van der Velpen V; Rosenberg N; Maillard V; Teav T; Chatton JY; Gallart-Ayala H; Ivanisevic J J Neurochem; 2021 Oct; 159(2):378-388. PubMed ID: 33829502 [TBL] [Abstract][Full Text] [Related]
19. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide mononucleotide ameliorates the depression-like behaviors and is associated with attenuating the disruption of mitochondrial bioenergetics in depressed mice. Xie X; Yu C; Zhou J; Xiao Q; Shen Q; Xiong Z; Li Z; Fu Z J Affect Disord; 2020 Feb; 263():166-174. PubMed ID: 31818774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]